What Is Ganirelix?

What is ganirelix, and why do I have to take it for IVF?
ByJohn Rinehart, MD, PhD, Reproductive Medicine Institute, Chicago
Fertility Specialist
Updated
Mar 2017
Hero Image

If you’re undergoing IVF, ganirelix is one of the medications you’ll probably be getting to know up close and personal. Reproductive endocrinologists prescribe it to help take control of your reproductive system by blocking the release of luteinizing hormone and delaying ovulation, so you won’t release an egg at the wrong time in your cycle.

You’ll probably need to inject ganirelix yourself (or have your partner do it for you). It’s taken subcutaneously — just under the skin — usually in the abdominal area. Side effects can include headache, or redness and swelling at the injection site.

Warning: If you stay on ganirelix for a relatively long amount of time it can feel like you’re going through menopause (hot flashes, vaginal dryness, etc.), but most of the time a fertility doctor will use it at a time in your cycle when estrogen levels are high, which will cut back on these symptoms.

Plus, more from The Bump:

Related Video

John Legend Gets Real on How IVF Changed His Relationship With Teigen

Nehal Aggarwal
Associate Editor
Published
11/15/2019

What Is GnRH Agonist?

Peter G. McGovern, MD, director, Division of Reproductive Endocrinology and Infertility, University of Medicine and Dentistry of New Jersey, Newark; medical director of University Reproductive Associates, Montclair, NJ
Fertility Specialist

Remembering the First IVF Mom

Sarah Yang
Published
06/21/2012

Sunlight Boosts IVF Success by Over A Third

Anisa Arsenault
Associate Editor

This Easy Diet Is Boosting IVF Success Rates

Anisa Arsenault
Associate Editor
Published
01/30/2018

Better Tools to Predict IVF Success

Anisa Arsenault
Associate Editor
Published
04/09/2015

Study Links IVF to Birth Defects

Leah Rocketto
Published
10/23/2012

Embryo Transfer?

John Rinehart, MD, PhD, Reproductive Medicine Institute, Chicago
Fertility Specialist

What Is Ovarian Hyperstimulation?

Peter G. McGovern, MD, director, Division of Reproductive Endocrinology and Infertility, University of Medicine and Dentistry of New Jersey, Newark; medical director of University Reproductive Associates, Montclair, NJ
Fertility Specialist